HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chen Yan Selected Research

Vincamine

11/2020Vinpocetine protects against the development of experimental abdominal aortic aneurysms.
1/2018An update on vinpocetine: New discoveries and clinical implications.
4/2017Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
5/2013Vinpocetine attenuates lipid accumulation and atherosclerosis formation.
11/2012Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration.
5/2010Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chen Yan Research Topics

Disease

36Neoplasms (Cancer)
06/2022 - 01/2007
29Inflammation (Inflammations)
01/2021 - 06/2002
12Breast Neoplasms (Breast Cancer)
01/2021 - 01/2007
10Atherosclerosis
01/2022 - 04/2002
10Heart Failure
01/2021 - 06/2003
10Myocardial Infarction
01/2017 - 04/2006
9Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 06/2002
8Fibrosis (Cirrhosis)
06/2021 - 11/2011
8Hypertrophy
06/2021 - 05/2004
8Neoplasm Metastasis (Metastasis)
11/2020 - 02/2014
8Hepatocellular Carcinoma (Hepatoma)
09/2020 - 09/2014
7Vascular Remodeling
01/2018 - 06/2008
6Heart Diseases (Heart Disease)
01/2022 - 01/2020
6Hyperplasia
01/2022 - 06/2008
6Pain (Aches)
03/2021 - 04/2015
6Ischemia
12/2020 - 04/2006
5Infections
11/2021 - 12/2008
5Leukemia
07/2021 - 03/2017
5Cardiomegaly (Heart Hypertrophy)
06/2021 - 11/2009
5Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2020 - 05/2010
5Cognitive Dysfunction
11/2020 - 05/2010
5Stroke (Strokes)
01/2020 - 10/2003
5Hypoxia (Hypoxemia)
01/2018 - 06/2005
5Infarction (Infarctions)
01/2017 - 04/2006
4Abdominal Aortic Aneurysm
01/2022 - 10/2015
4Sepsis (Septicemia)
01/2022 - 01/2020
4Pneumonia (Pneumonitis)
01/2021 - 10/2003
4Non-alcoholic Fatty Liver Disease
01/2021 - 01/2014
4Chronic Obstructive Pulmonary Disease (COPD)
07/2020 - 12/2008
4Carcinogenesis
01/2020 - 01/2014
4Lung Neoplasms (Lung Cancer)
01/2019 - 04/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 03/2012
4Necrosis
01/2019 - 01/2009
3Liver Neoplasms (Liver Cancer)
04/2021 - 01/2016
3Obesity
01/2021 - 07/2014
3Lymphatic Metastasis
11/2020 - 06/2017
3Otitis Media
01/2020 - 12/2008
3Asthma (Bronchial Asthma)
04/2019 - 01/2017
3Body Weight (Weight, Body)
04/2019 - 03/2012
3Liver Diseases (Liver Disease)
10/2016 - 04/2004
3Reperfusion Injury
11/2013 - 08/2008
2Esophageal Squamous Cell Carcinoma
06/2022 - 01/2021
2Radiation Injuries (Radiation Sickness)
01/2022 - 02/2017
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2018
2Aortic Aneurysm (Aneurysm, Aortic)
01/2022 - 06/2009
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2021
2Aneurysm (Aneurysms)
01/2022 - 01/2021
2Dysbiosis
11/2021 - 01/2021
2Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 01/2017
2Colonic Neoplasms (Colon Cancer)
06/2021 - 02/2014
2Postoperative Pain
03/2021 - 11/2020

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2011
12Pharmaceutical PreparationsIBA
01/2022 - 10/2014
11vinpocetineIBA
11/2020 - 05/2010
10Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2021 - 05/2005
8Cyclic NucleotidesIBA
01/2021 - 11/2009
8Biological ProductsIBA
01/2021 - 01/2016
8MicroRNAs (MicroRNA)IBA
01/2021 - 04/2014
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
7Angiotensin IIIBA
01/2021 - 10/2004
6CytokinesIBA
01/2022 - 10/2003
6AlkaloidsIBA
11/2020 - 05/2010
6VincamineIBA
11/2020 - 05/2010
6Interleukin-6 (Interleukin 6)IBA
09/2020 - 01/2017
5Isoproterenol (Isoprenaline)FDA LinkGeneric
06/2021 - 05/2005
5Messenger RNA (mRNA)IBA
01/2021 - 04/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 10/2003
5NF-kappa B (NF-kB)IBA
05/2010 - 06/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 04/2019
4Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2007
4Insulin (Novolin)FDA Link
01/2022 - 01/2018
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2016
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 06/2008
4CateninsIBA
01/2019 - 12/2010
3ChitosanIBA
11/2021 - 07/2015
3Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 06/2020
3Opioid Analgesics (Opioids)IBA
03/2021 - 02/2020
3EnzymesIBA
01/2021 - 04/2017
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 04/2012
3Ligases (Synthetase)IBA
12/2020 - 12/2010
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2020 - 01/2020
3AntioxidantsIBA
04/2019 - 05/2006
3Protein Isoforms (Isoforms)IBA
04/2017 - 12/2010
3Small Interfering RNA (siRNA)IBA
04/2017 - 11/2009
3Phosphodiesterase 3 InhibitorsIBA
11/2013 - 05/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2012 - 04/2002
3Cyclophilin AIBA
05/2011 - 06/2008
2salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2017
2Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2018
2Phosphodiesterase 5 InhibitorsIBA
01/2022 - 11/2012
2higenamine (norcoclaurine)IBA
06/2021 - 02/2016
2ArginaseIBA
01/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020

Therapy/Procedure

20Therapeutics
11/2021 - 10/2003
6Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2018 - 02/2010
5Radiotherapy
06/2022 - 02/2017
3Aftercare (After-Treatment)
12/2020 - 02/2007
3Mammaplasty (Breast Reconstruction)
11/2020 - 07/2014
3Length of Stay
02/2020 - 03/2014